Skip to content
The Policy VaultThe Policy Vault

Inrebic (fedratinib capsules) — Cigna

Myelofibrosis (primary, post-polycythemia vera, or post-essential thrombocythemia)

Initial criteria

  • Patient is age ≥ 18 years AND
  • Patient has higher-risk disease

Approval duration

1 year